全文获取类型
收费全文 | 3205篇 |
免费 | 169篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 38篇 |
儿科学 | 197篇 |
妇产科学 | 45篇 |
基础医学 | 410篇 |
口腔科学 | 179篇 |
临床医学 | 270篇 |
内科学 | 705篇 |
皮肤病学 | 79篇 |
神经病学 | 101篇 |
特种医学 | 505篇 |
外科学 | 252篇 |
综合类 | 32篇 |
一般理论 | 1篇 |
预防医学 | 243篇 |
眼科学 | 24篇 |
药学 | 188篇 |
中国医学 | 15篇 |
肿瘤学 | 119篇 |
出版年
2023年 | 17篇 |
2022年 | 57篇 |
2021年 | 88篇 |
2020年 | 57篇 |
2019年 | 60篇 |
2018年 | 101篇 |
2017年 | 59篇 |
2016年 | 62篇 |
2015年 | 76篇 |
2014年 | 90篇 |
2013年 | 154篇 |
2012年 | 176篇 |
2011年 | 156篇 |
2010年 | 135篇 |
2009年 | 116篇 |
2008年 | 113篇 |
2007年 | 96篇 |
2006年 | 91篇 |
2005年 | 72篇 |
2004年 | 70篇 |
2003年 | 56篇 |
2002年 | 79篇 |
2001年 | 41篇 |
2000年 | 59篇 |
1999年 | 51篇 |
1998年 | 136篇 |
1997年 | 123篇 |
1996年 | 128篇 |
1995年 | 94篇 |
1994年 | 79篇 |
1993年 | 81篇 |
1992年 | 33篇 |
1991年 | 26篇 |
1990年 | 24篇 |
1989年 | 67篇 |
1988年 | 51篇 |
1987年 | 57篇 |
1986年 | 51篇 |
1985年 | 53篇 |
1984年 | 25篇 |
1983年 | 33篇 |
1982年 | 36篇 |
1981年 | 21篇 |
1980年 | 36篇 |
1979年 | 18篇 |
1978年 | 16篇 |
1977年 | 17篇 |
1976年 | 23篇 |
1975年 | 24篇 |
1971年 | 4篇 |
排序方式: 共有3403条查询结果,搜索用时 15 毫秒
91.
Immunologic status of hemophilia patients treated with cryoprecipitate or lyophilized concentrate 总被引:1,自引:0,他引:1
We evaluated 37 patients with moderate or severe hemophilia A and six patients with severe factor IX deficiency for clinical or laboratory evidence of immune abnormalities. Patients were assigned to one of four groups according to the type of clotting factor replacement. Twenty patients had received only cryoprecipitate during the two years preceding the evaluation (group I); 11 additional patients were treated predominantly with cryoprecipitate but had also received up to nine bottles of factor VIII concentrate (group II); six patients received factor VIII concentrate (group III); six patients received factor IX concentrate (group IV). There was no clinical or laboratory evidence of immunodeficiency among the 43 patients. The mean absolute number of Th cells was normal in all patient groups, but the mean absolute number of Ts cells was increased compared with controls, both in patients treated with cryoprecipitate and in patients treated with factor VIII or factor IX concentrate. There was no correlation between the Th/Ts ratio and patient age, alanine aminotransferase level, hepatitis serology, in vitro lymphocyte function, or amount of clotting factor administered. Our observations demonstrate that the volunteer or commercial origin of clotting factor replacement cannot fully explain the alterations in lymphocyte subset distribution previously described in patients with hemophilia A. 相似文献
92.
Débora Nunes Mario Josep Guarro Janio Morais Santurio Sydney Hartz Alves Javier Capilla 《Antimicrobial agents and chemotherapy》2015,59(8):5018-5021
We evaluated the combination of posaconazole with amphotericin B in vitro and in a murine model of systemic infections caused by Sporothrix brasiliensis and Sporothrix schenckii
sensu stricto. In vitro data demonstrated a synergistic effect, and although posaconazole alone was effective against sporotrichosis, efficacy in terms of survival and burden reduction was increased with the combination. This combination might be an option against disseminated sporotrichosis, especially when itraconazole or amphotericin B at optimal doses are contraindicated. 相似文献
93.
Corzo D; Yunis JJ; Salazar M; Lieberman JA; Howard A; Awdeh Z; Alper CA; Yunis EJ 《Blood》1995,86(10):3835-3840
Genes of the major histocompatibility complex (MHC) have been associated with susceptibility to drug-induced adverse reactions. We previously found that clozapine-induced agranulocytosis (CA) is associated with the HLA-DRB1*0402, DRB4*0101, DQB1*0302, DQA1*0301 haplotype in Ashkenazi Jewish patients and with the HLA-DRB1*1601, DRB5*02, DQB1*0502, DQA1*0102 haplotype in non-Jewish patients. In the present study, we tested the hypothesis that the variants of the heat- shock protein 70 (HSP-70) encoded by the HSP-70 loci located within the MHC region and known to be involved in apoptosis and regulation of cell proliferation could play an important role in molecular mechanisms of CA. First, we analyzed HSP70-2 polymorphism in risk-associated haplotypes from HLA homozygous cells and normal individuals and confirmed that the HSP70-2 9-kb variant was associated invariably with DR4 (HLA-DRB1*0402, DQB1*0302) and DR2 (HLA-DRB1*01601, DQB1*0502, DQA1*0102 and HLA-DRB1*1501, DQB1*0602) haplotypes, which were the haplotypes found increased in Jewish and non-Jewish patients with CA, respectively. The 9.0-kb variant was also found to be associated with HLA-B44, DRB1*0401 and HLA-B44, DRB1*07 haplotypes. Second, in patients with CA (12 Ashkenazi Jewish and 20 non-Jewish patients), HSP70-1 A and HSP70-2 9.0-kb variants were associated with the MHC haplotypes found by us to be markers of susceptibility to CA. The clozapine-treated control group had an excess number of HSP70-1 C and HSP70-2 8.5-kb variants, consistent with genetic resistance to CA associated with those variants. This finding supports our hypothesis that a dominant gene within the MHC region (marked by HSP70-1 and HSP70-2), but not necessarily HLA, is associated with CA in two different ethnic groups. 相似文献
94.
Winck JC Vitacca M Morais A Barbano L Porta R Teixeira-Pinto A Ambrosino N 《Chest》2004,126(2):382-388
STUDY OBJECTIVES: To compare the tolerance and physiologic effects of a 5-night treatment with either nasal proportional assist ventilation (PAV) or pressure support ventilation (PSV) in patients with chronic ventilatory failure. DESIGN: Cross-over, randomized, controlled study. SETTING: Rehabilitation units of pneumology department. PATIENTS OR PARTICIPANTS: Four patients with COPD and 10 patients with restrictive thoracic diseases with chronic hypercapnia (median baseline Paco(2), 55.1 mm Hg) were studied. INTERVENTIONS: In a cross-over study, nasal PAV and PSV set at the patient's comfort were randomly applied during 5 consecutive nights (with a 2-night washout period). MEASUREMENTS AND RESULTS: Continuous nocturnal pulse oximetric saturation (Spo(2)) and arterial blood gas results at wake-up were evaluated at baseline during spontaneous breathing and on the fifth day of ventilatory support. Dyspnea, sleep quality, adaptation, and comfort at inspiration and expiration by visual analog scale (VAS) were evaluated every day as well as a side effects score. On the fifth day, there were no significant differences in daytime Paco(2) (median PAV, 53.3 mm Hg; median PSV, 50.2; p = 0.168). Mean nocturnal Spo(2) improved significantly with both PAV and PSV without any significant differences between modes (baseline median, 92%; PAV median, 94.5%; PSV median, 95%). The percentage of the study night spent < 90% Spo(2) (T90) was slightly but significantly higher with PAV than with PSV (median PAV T90, 4%; median PSV T90, 2%; p = 0.049). The VAS symptom score was similar at day 5 between modes; however, nasal and oral dryness were lower (p = 0.05) and alarm noise was higher (p = 0.037) with PAV. CONCLUSIONS: After 5 days of treatment, both modes had similar tolerance, and were equally effective in reducing daytime hypercapnia and improving nocturnal saturation and symptoms. However, PAV induced less nasal and oral dryness but was associated with higher alarm noise. 相似文献
95.
Jelinek J; Fairbairn LJ; Dexter TM; Rafferty JA; Stocking C; Ostertag W; Margison GP 《Blood》1996,87(5):1957-1961
A human O6-alkylguanine-DNA-alkyltransferase (ATase) cDNA-containing retrovirus was used to infect murine long-term primary bone marrow cultures. High levels of ATase expression were obtained, and colony- forming cells of the granulocyte-macrophage lineage from the cultures transduced with the human ATase retrovirus were three times more resistant to the alkylating agent, N-methyl-N-nitrosourea (MNU), than control cultures. Furthermore, expression of the human ATase protected long-term hematopoiesis, measured as the output of progenitor cells to the nonadherent fraction of the culture, against the cytotoxic effects of repeated exposures to MNU. These results clearly show that a human ATase cDNA-containing retrovirus can be used to infect long-term primary bone marrow cultures and that this attenuates their sensitivity to nitrosoureas. 相似文献
96.
97.
Joycellane Alline do Nascimento Campos Ribeiro Alexandre Coellho Serquiz Priscila Fabíola dos Santos Silva Patrícia Batista Barra Medeiros Barbosa Tarcísio Bruno Montenegro Sampaio Raimundo Fernandes de Araújo Junior Adeliana Silva de Oliveira Richele Janaina Araújo Machado Bruna Leal Lima Maciel Adriana Ferreira Uch?a Elizeu Antunes dos Santos Ana Heloneida de Araújo Morais 《Clinics (S?o Paulo, Brazil)》2015,70(2):136-143
OBJECTIVES:
Seeds are excellent sources of proteinase inhibitors, some of which may have satietogenic and slimming actions. We evaluated the effect of a trypsin inhibitor from Tamarindus indica L. seeds on weight gain, food consumption and cholecystokinin levels in Wistar rats.METHODS:
A trypsin inhibitor from Tamarindus was isolated using ammonium sulfate (30–60%) following precipitation with acetone and was further isolated with Trypsin-Sepharose affinity chromatography. Analyses were conducted to assess the in vivo digestibility, food intake, body weight evolution and cholecystokinin levels in Wistar rats. Histological analyses of organs and biochemical analyses of sera were performed.RESULTS:
The trypsin inhibitor from Tamarindus reduced food consumption, thereby reducing weight gain. The in vivo true digestibility was not significantly different between the control and Tamarindus trypsin inhibitor-treated groups. The trypsin inhibitor from Tamarindus did not cause alterations in biochemical parameters or liver, stomach, intestine or pancreas histology. Rats treated with the trypsin inhibitor showed significantly elevated cholecystokinin levels compared with animals receiving casein or water.CONCLUSION:
The results indicate that the isolated trypsin inhibitor from Tamarindus reduces weight gain by reducing food consumption, an effect that may be mediated by increased cholecystokinin. Thus, the potential use of this trypsin inhibitor in obesity prevention and/or treatment should be evaluated. 相似文献98.
99.
100.
da Costa Iwyson Henrique Fernandes Silva Renan Morais e Carlos Juliana de Oliveira Silva Maria Cleonice Araújo Pinheiro Maria Karine Cavalcante Martins Bruna Cristina Cardoso Fernandes Paula Frassinetti Castelo Branco Camurça Guedes Marjorie Moreira 《International journal of clinical pharmacy》2019,41(4):888-894